Pages

▼
Wednesday, November 14, 2012

The end of "Viral Matters" here on the Internets...

›
Because of a new industry gig and the dangers of being non-compliant, I'm having to shut-down 'Viral Matters' here on the intern...
1 comment:
Monday, October 15, 2012

Initial Abbott Labs interferon-free triple combination data released...

›
Posted 10/15/12 on Trust.org . The pre-AASLD press release parade is in full swing!! This time Abbott Labs checks in with some pretty impre...
1 comment:
Thursday, October 11, 2012

Australia's Benitec Biopharma to purchase Tacere Therapeutics and it's new HCV drug...

›
Posted 10-11-2012 on www.LifeScience.com.au . Australia's Benitec Biopharma is set to purchase San Jose, CA - based Tacere Therapeutics...
1 comment:
Monday, October 8, 2012

New HCV Resistance slide deck available from The Center for HIV Identification, Prevention, and Treatment Services (CHIPTS)

›
The great folks at CHIPTS, in collaboration from The Forum for Collaborative HIV Research have revised and updated their initial HCV resist...
1 comment:
Tuesday, October 2, 2012

Aethlon Medical releases HCV treatment protocol details for Hemopurifier medical device...

›
Posted 10/2/2012 on Fox News.com . Aethlon Medical, Inc, whose Hemopurifier filtration device is being studied in India for a variety of in...
Thursday, September 27, 2012

Achillion announces positive POC data for ACH-3102...

›
Posted 9-27-12 on the  Achillion website . Achillion announces positive proof-of-concept data with it's second generation pan-genotypic...
1 comment:
Tuesday, September 25, 2012

Vertex Pharmaceuticals / Alios BioPharma HCV nuc update...

›
Posted on 9-25-12 on ClinicaSpace.com . Vertex Pharmaceuticals will continue to develop one nucleotide inhibtior in it's collaboration ...
4 comments: